<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Am J Hum Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Hum. Genet</journal-id>
<journal-title-group>
<journal-title>American Journal of Human Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0002-9297</issn>
<issn pub-type="epub">1537-6605</issn>
<publisher>
<publisher-name>Elsevier</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27666371</article-id>
<article-id pub-id-type="pmc">5065687</article-id>
<article-id pub-id-type="publisher-id">S0002-9297(16)30369-X</article-id>
<article-id pub-id-type="doi">10.1016/j.ajhg.2016.08.015</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Increasing Generality and Power of Rare-Variant Tests by Utilizing Extended Pedigrees</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Sul</surname>
<given-names>Jae Hoon</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cade</surname>
<given-names>Brian E.</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cho</surname>
<given-names>Michael H.</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qiao</surname>
<given-names>Dandi</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Silverman</surname>
<given-names>Edwin K.</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Redline</surname>
<given-names>Susan</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sunyaev</surname>
<given-names>Shamil</given-names>
</name>
<email>ssunyaev@rics.bwh.harvard.edu</email>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff7">7</xref>
<xref ref-type="corresp" rid="cor1">∗</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>Division of Genetics, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA</aff>
<aff id="aff2"><label>2</label>Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA 90095, USA</aff>
<aff id="aff3"><label>3</label>Division of Sleep and Circadian Disorders, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA</aff>
<aff id="aff4"><label>4</label>Channing Division of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA</aff>
<aff id="aff5"><label>5</label>Division of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA</aff>
<aff id="aff6"><label>6</label>Division of Pulmonary, Critical Care, and Sleep Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA</aff>
<aff id="aff7"><label>7</label>Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA</aff>
<author-notes>
<corresp id="cor1"><label>∗</label>Corresponding author <email>ssunyaev@rics.bwh.harvard.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>06</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>22</day>
<month>9</month>
<year>2016</year>
</pub-date>
<volume>99</volume>
<issue>4</issue>
<fpage>846</fpage>
<lpage>859</lpage>
<history>
<date date-type="received">
<day>13</day>
<month>2</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>8</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© 2016.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder></copyright-holder>
</permissions>
<abstract id="abs0010">
<p>Recently, multiple studies have performed whole-exome or whole-genome sequencing to identify groups of rare variants associated with complex traits and diseases. They have primarily utilized case-control study designs that often require thousands of individuals to reach acceptable statistical power. Family-based studies can be more powerful because a rare variant can be enriched in an extended pedigree and segregate with the phenotype. Although many methods have been proposed for using family data to discover rare variants involved in a disease, a majority of them focus on a specific pedigree structure and are designed to analyze either binary or continuously measured outcomes. In this article, we propose RareIBD, a general and powerful approach to identifying rare variants involved in disease susceptibility. Our method can be applied to large extended families of arbitrary structure, including pedigrees with only affected individuals. The method accommodates both binary and quantitative traits. A series of simulation experiments suggest that RareIBD is a powerful test that outperforms existing approaches. In addition, our method accounts for individuals in top generations, which are not usually genotyped in extended families. In contrast to available statistical tests, RareIBD generates accurate p values even when genetic data from these individuals are missing. We applied RareIBD, as well as other methods, to two extended family datasets generated by different genotyping technologies and representing different ethnicities. The analysis of real data confirmed that RareIBD is the only method that properly controls type I error.</p>
</abstract>
</article-meta>
<notes>
<p id="misc0010">Published: September 22, 2016</p>
</notes>
</front>
</article>
</pmc-articleset>